Zobrazeno 1 - 10
of 98
pro vyhledávání: '"AHMET ÖZET"'
Autor:
Orhun Akdogan, Betul Ogut, Osman Sutcuoglu, Aysenur Sert, Fatih Gurler, Nalan Akyurek, Nuriye Ozdemir, Ahmet Ozet, Ozan Yazici
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Growth differentiation factor-15 (GDF-15), a member of the TGF-β superfamily, is overexpressed in various cancers and facilitates immune evasion by inhibiting T-cell activation. GDFATHER-TRIAL’s phase 2a results demonstrated pr
Externí odkaz:
https://doaj.org/article/db4a573e19b24f1c82b55dbc73a1b3e1
Autor:
Yasar Subutay Peker, Mehmet Fatih Can, Ismail Hakki Ozerhan, Gokhan Yagci, Nazif Zeybek, Kutan Kavakli, Sedat Gurkok, Alper Gozubuyuk, Onur Genc, Gokhan Erdem, Ahmet Ozet, Mustafa Gerek, Yusuf Peker
Publikováno v:
Case Reports in Surgery, Vol 2018 (2018)
The main method of fighting against colon cancer is targeted treatment. BRAF inhibitors, which are accepted as standard treatment for V600E mutant malign melanomas, are the newest approach for targeted treatment of V600E mutant colorectal cancers. In
Externí odkaz:
https://doaj.org/article/17753d1cf366468c9b94b7a4d65b2878
Autor:
Fatih Gürler, Fatih Tay, Zehra Sucuoğlu İşleyen, Tahir Yerlikaya, Engin Hendem, Selin Aktürk Esen, Osman Sütçüoğlu, Deniz Işık, Büşra Niğdelioğlu, Miraç Özen, Elif Şahin, Teoman Şakalar, Nilay Şengül Samancı, Özkan Alan, İlhan Hacıbekiroğlu, Efnan Algın, Melek Karakurt Yılmaz, Hacı Mehmet Türk, Berna Öksüzoğlu, Aydın Yavuz, Osman Yüksel, Hüseyin Bora, Ozan Yazıcı, Ahmet Özet, Nuriye Özdemir
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Background Neoadjuvant treatment is the standard treatment in locally advanced ESCC. However, the optimal chemotherapy regimen is not known. Method This is a retrospective observational cohort study conducted with propensity score matching.
Externí odkaz:
https://doaj.org/article/0c2407cd5a0448378847928577fc42af
Autor:
Volkan Aslan, Atiye Cenay Karabörk Kılıç, Ahmet Özet, Aytuğ Üner, Nazan Günel, Ozan Yazıcı, Gözde Savaş, Ahmet Bayrak, Emrah Eraslan, Berna Öksüzoğlu, Hüseyin Koray Kılıç, Nuriye Özdemir
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Introduction Resistance to immune checkpoint inhibitors (ICI) is a significant issue in metastatic renal cell carcinoma (mRCC), as it is in the majority of cancer types. An important deficiency in immunooncology today is the lack of a predic
Externí odkaz:
https://doaj.org/article/064c7efbc4eb4b068e1b246c055dc512
Publikováno v:
Case Reports in Medicine, Vol 2009 (2009)
18F-FDG PET is a useful and sensitive imaging method for a variety of malignancies, however, the specificity is low in active infections and inflammatory diseases. We describe a female patient with stage IIIA breast cancer in first complete remission
Externí odkaz:
https://doaj.org/article/cfcd9e23251d4497a03cbd1257d68b06
Autor:
Bediz Kurt İnci, Elif Acar, Fatih Gürler, Ayşegül İlhan, Fatih Yıldız, Fisun Ardıç, Berna Öksüzoğlu, Nuriye Özdemir, Ahmet Özet, Güldal Esendağlı, Ozan Yazıcı
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 12, p 3620 (2024)
Introduction: The current study aims to evaluate the OX40, TIM-3, LAG-3, and PD-L1 targeted pathways in the regulation of T-cell activity in sarcoma patients to determine their relationship with overall survival (OS). Method: This study included one
Externí odkaz:
https://doaj.org/article/5e999b2478e1404e86faa7429e5db21b
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 3, p 843 (2024)
Background: Prior speculation suggests that selective 5-hydroxytryptamine-3 receptors and neurokinin-1 receptor antagonists may increase arrhythmia risk and induce electrocardiographic changes. This study examined the effect of anti-emetic medication
Externí odkaz:
https://doaj.org/article/e7c65390d8764108b54114e601703693
Autor:
Vahit Özmen, Nergiz Dağoğlu, İsmet Dede, Adem Akçakaya, Mustafa Kerem, Fatih Göksel, Enver Özgür, Emel Başkan, Mustafa Yaylacı, Adil Ceydeli, Meltem Baykara, Huriye Şenay Kızıltan, Şeref Kömürcü, Mahmut Gümüş, H. Mehmet Türk, Recep Demirhan, Ali Akgün, Naim Kadoglou, Emre Yatman, Cem Cüneyt Elbi, Seza Güleç, Atilla Soran, Ahmet Özet, Fahrettin Keleştimur
Publikováno v:
European Journal of Breast Health, Vol 12, Iss 1, Pp 9-17 (2016)
Objective:There is an increase in the incidence of cancer, and consequently in mortality rates, both in the world and in Turkey. The increase in the incidence and mortality rate of cancer are more prominent in our country as well as in other developi
Externí odkaz:
https://doaj.org/article/56340ace63934487a5c4897ad1757361
Publikováno v:
Turkish Journal of Hematology, Vol 35, Iss 2, Pp 145-146 (2018)
Externí odkaz:
https://doaj.org/article/2980bcbfe9034291a2f4bb6d647a2dfe
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 27, Iss 3, Pp 161-163 (2015)
The prognosis of metastatic melanoma is poor. Pre-targeted treatment era, the combination of interferon-α (IF-α) plus chemotherapy had been used and have generally short response duration. Herein, we present a metastatic melanoma case that achieved
Externí odkaz:
https://doaj.org/article/eaf578311c144b51b0a3b16980bd499c